US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
ATE81467T1
(de)
|
1987-02-24 |
1992-10-15 |
Xoma Corp |
Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
|
US5912017A
(en)
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US5849572A
(en)
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5679347A
(en)
|
1992-12-10 |
1997-10-21 |
Brigham And Women's Hospital |
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
WO1995003035A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
BR9407956A
(pt)
|
1993-10-25 |
1996-11-26 |
Canji Inc |
Composiçao farmacêutica vetor de express o de adenovirus recombinante e kit par reduzir a proliferaçao de células tumorais
|
TW249754B
(ja)
|
1993-10-26 |
1995-06-21 |
Alpha I Biomedicals Inc |
|
JP3872813B2
(ja)
|
1994-05-18 |
2007-01-24 |
エス.ピー.アイ. シンセティック ペプチデス インコーポレイテッド |
ヘテロダイマーポリペプチド免疫原キャリア組成物および方法
|
EP0784690B1
(en)
|
1994-06-10 |
2006-08-16 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
EP0804076A4
(en)
*
|
1994-10-19 |
1998-10-21 |
Genetic Therapy Inc |
GENTHERAPY THROUGH SIMULTANEOUS AND REPEATED ADMINISTRATION OF ADENOVIRUS AND IMMUNE SUPPRESSIVES
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
DE69630514D1
(de)
|
1995-01-05 |
2003-12-04 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
US6251957B1
(en)
|
1995-02-24 |
2001-06-26 |
Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
ES2333425T5
(es)
|
1995-06-15 |
2012-08-28 |
Crucell Holland B.V. |
Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
JP3462313B2
(ja)
|
1995-08-24 |
2003-11-05 |
キッコーマン株式会社 |
変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体dna及び変異型ウリカーゼの製造法
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
US5837511A
(en)
|
1995-10-02 |
1998-11-17 |
Cornell Research Foundation, Inc. |
Non-group C adenoviral vectors
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
US6893664B1
(en)
|
1996-06-17 |
2005-05-17 |
Powderject Research Limited |
Particle delivery techniques
|
US6258823B1
(en)
|
1996-07-12 |
2001-07-10 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
AU4176497A
(en)
*
|
1996-09-03 |
1998-03-26 |
Health Research Inc. |
Treatment of antigen presenting cells to modulate antigen presenting cell fun ction
|
US5814500A
(en)
|
1996-10-31 |
1998-09-29 |
The Johns Hopkins University School Of Medicine |
Delivery construct for antisense nucleic acids and methods of use
|
CZ227199A3
(cs)
|
1996-12-27 |
1999-12-15 |
Icn, Pharmaceuticals, Inc. |
Aptamer
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
US5849561A
(en)
|
1997-05-22 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method for the production of non-group C adenoviral vectors
|
EP0996735B1
(en)
|
1997-06-09 |
2003-12-10 |
Genvec, Inc. |
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
EP0894853A1
(en)
|
1997-07-24 |
1999-02-03 |
Gesellschaft für Biotechnologische Forschung mbH (GBF) |
Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use
|
EP1002119A1
(en)
|
1997-07-31 |
2000-05-24 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Targeted hsv vectors
|
DE69831417T2
(de)
|
1997-09-23 |
2006-06-22 |
Genvec, Inc. |
Duale selektionkassette und sie enthaltende plasmide
|
EP2042192A3
(en)
|
1997-10-30 |
2009-05-27 |
Laboratorios LETI, S.L. |
Tolerogenic fragments of natural allergens
|
US6018817A
(en)
|
1997-12-03 |
2000-01-25 |
International Business Machines Corporation |
Error correcting code retrofit method and apparatus for multiple memory configurations
|
US6197229B1
(en)
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
CA2316414A1
(en)
|
1997-12-23 |
1999-07-01 |
Introgene B.V. |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
GB2348808B
(en)
|
1998-01-09 |
2003-03-19 |
Circassia Ltd |
Methods and compositions for desensitisation
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
WO1999054441A1
(en)
|
1998-04-22 |
1999-10-28 |
Genvec, Inc. |
Efficient purification of adenovirus
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
US5965358A
(en)
|
1998-08-26 |
1999-10-12 |
Genvec, Inc. |
Method for assessing the relative purity of viral gene transfer vector stocks
|
US6306640B1
(en)
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
WO2000020040A1
(en)
|
1998-10-08 |
2000-04-13 |
University Of Massachusetts |
Controlling gene expression in living cells
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
US6764675B1
(en)
|
1999-06-08 |
2004-07-20 |
The Uab Research Foundation |
Herpes simplex virus expressing foreign genes and method for treating cancers therewith
|
DE19951970A1
(de)
|
1999-10-28 |
2001-05-03 |
Bionetworks Gmbh |
Arzneimittel für die Toleranzinduktion
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス, インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
WO2001068133A1
(en)
|
2000-03-14 |
2001-09-20 |
Genetics Institute, Inc. |
Use of rapamycin and agents that inhibit b7 activity in immunomodulation
|
US6168941B1
(en)
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
CA2410828C
(en)
|
2000-06-01 |
2012-01-24 |
University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
AU2001269923A1
(en)
|
2000-06-19 |
2002-01-02 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
US20020014242A1
(en)
|
2000-07-31 |
2002-02-07 |
Abraham Scaria |
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
EP1191097A1
(en)
|
2000-09-21 |
2002-03-27 |
Leids Universitair Medisch Centrum |
Induction of exon skipping in eukaryotic cells
|
US6447995B1
(en)
|
2000-10-04 |
2002-09-10 |
Genvec, Inc. |
Utilizing intrinsic fluorescence to detect adenovirus
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
CA2440367A1
(en)
|
2000-10-20 |
2002-08-15 |
Canji, Inc. |
Aptamer-mediated regulation of gene expression
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
AU2002338571A1
(en)
|
2001-04-11 |
2002-11-11 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for suppressing immune responses
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
AU2002327412A1
(en)
|
2001-08-02 |
2003-02-17 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
CN1294268C
(zh)
*
|
2001-09-03 |
2007-01-10 |
上海三维生物技术有限公司 |
可在肿瘤细胞内特异性复制并扩散的重组腺病毒载体
|
JP4790984B2
(ja)
|
2001-09-06 |
2011-10-12 |
アルファヴァックス,インコーポレイテッド |
アルファウイルスレプリコンベクター系
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
DK1436321T3
(da)
|
2001-10-19 |
2006-11-13 |
Isotechnika Inc |
Syntese af cyclosporinanaloger
|
AU2002360291A1
(en)
|
2001-12-17 |
2003-06-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 8 sequences
|
GB0207440D0
(en)
|
2002-03-28 |
2002-05-08 |
Ppl Therapeutics Scotland Ltd |
Tolerogenic antigen-presenting cells
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
WO2003102162A2
(en)
|
2002-06-04 |
2003-12-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Novel tolerogenic dendritic cells and therapeutic uses therefor
|
CA2494508A1
(en)
|
2002-07-03 |
2004-01-15 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
CA2392863A1
(en)
|
2002-07-08 |
2004-01-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A high capacity recombinant adenoviral vector for treatment of hemophilia a
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
ATE404196T1
(de)
|
2002-11-29 |
2008-08-15 |
Maria Grazia Roncarolo |
Rapamycin und il-10 zur behandlung von autoimmunerkrankungen
|
AU2003296958A1
(en)
|
2002-12-13 |
2004-07-09 |
Genetix Pharmaceuticals, Inc. |
Therapeutic retroviral vectors for gene therapy
|
US7510872B2
(en)
|
2003-02-26 |
2009-03-31 |
Nationwide Children's Hospital |
Recombinant adeno-associated virus production
|
NZ542323A
(en)
|
2003-03-26 |
2008-07-31 |
Cytos Biotechnology Ag |
Melan-A peptide analogue-virus-like-particle conjugates
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
WO2005019429A2
(en)
|
2003-08-22 |
2005-03-03 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
US20060251711A1
(en)
|
2003-08-28 |
2006-11-09 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
WO2005038035A2
(en)
|
2003-10-15 |
2005-04-28 |
University Of Iowa Research Foundation |
Methods for producing and using in vivo pseudotyped retroviruses
|
CA2548179A1
(en)
|
2003-12-02 |
2005-07-21 |
Cytimmune Sciences, Inc. |
Methods and compositions for the production of monoclonal antibodies
|
KR101376715B1
(ko)
|
2003-12-19 |
2014-03-27 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
소프트 또는 임프린트 리소그래피를 이용하여 분리된 마이크로- 및 나노- 구조를 제작하는 방법
|
US7947659B2
(en)
|
2004-03-12 |
2011-05-24 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeting VEGF
|
EA017893B1
(ru)
|
2004-04-08 |
2013-04-30 |
Лаборатуар Сероно Са |
Композиции, содержащие ингибитор jnk и циклоспорин
|
ES2361325T3
(es)
|
2004-06-28 |
2011-06-16 |
The University Of Western Australia |
Oligonucleótidos antisentido para inducir la omisión de exón y métodos de uso de los mismos.
|
CA2571899A1
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
FR2874384B1
(fr)
*
|
2004-08-17 |
2010-07-30 |
Genethon |
Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
|
JP2008514202A
(ja)
|
2004-09-24 |
2008-05-08 |
ニュークレオニクス・インコーポレイテッド |
Rnaiによる一本鎖ウイルスの逆鎖複製中間体のターゲティング
|
EP1812061A2
(en)
|
2004-10-05 |
2007-08-01 |
Tanox Inc. |
Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy
|
US20060089324A1
(en)
|
2004-10-22 |
2006-04-27 |
Sailen Barik |
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
|
US7790878B2
(en)
|
2004-10-22 |
2010-09-07 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
|
US20090028948A1
(en)
|
2004-12-31 |
2009-01-29 |
Iceutica Pty Ltd |
Nanoparticle composition and methods of synthesis thereof
|
NZ560936A
(en)
|
2005-02-03 |
2010-04-30 |
Benitec Inc |
RNAI expression constructs
|
MX2007010008A
(es)
|
2005-02-16 |
2008-01-18 |
Lentigen Corp |
Vectores lentivirales y su uso.
|
GB0504206D0
(en)
|
2005-03-01 |
2005-04-06 |
Glaxo Group Ltd |
Combination therapy
|
CN101137365A
(zh)
|
2005-03-08 |
2008-03-05 |
生命周期药物公司 |
包含西罗莫司和/或其类似物的药物组合物
|
CA2601312A1
(en)
|
2005-03-17 |
2006-09-28 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
CA2603987A1
(en)
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
AU2006243960A1
(en)
|
2005-05-10 |
2006-11-16 |
Emory University |
Strategies for delivery of active agents using micelles and particles
|
CA2609276A1
(en)
|
2005-05-23 |
2006-11-30 |
De-Chu C. Tang |
Rapid production of adenovirus-free recombinant adenovirus vectors
|
TW200711649A
(en)
|
2005-06-17 |
2007-04-01 |
Combinatorx Inc |
Combination therapy for the treatment of immunoinflammatory disorders
|
WO2007002718A2
(en)
|
2005-06-27 |
2007-01-04 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of hif-1 and theraputic uses thereof
|
WO2007024026A1
(ja)
|
2005-08-25 |
2007-03-01 |
Taiho Pharmaceutical Co., Ltd. |
T細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
CN1979166A
(zh)
|
2005-11-30 |
2007-06-13 |
北京有色金属研究总院 |
一种制备免疫检测用纳米胶体金的工艺方法及其反应装置
|
EP2345412A1
(en)
|
2005-12-02 |
2011-07-20 |
The Johns Hopkins University |
Use of high-dose oxazaphosphorine drugs for treating immune disorders
|
AU2006321890A1
(en)
|
2005-12-08 |
2007-06-14 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for expanding T regulatory cells
|
US20070249043A1
(en)
|
2005-12-12 |
2007-10-25 |
Mayall Timothy P |
Adenoviral expression vectors
|
GB0526211D0
(en)
|
2005-12-22 |
2006-02-01 |
Oxford Biomedica Ltd |
Viral vectors
|
US20100028450A1
(en)
|
2006-01-25 |
2010-02-04 |
The Board Of Trustees Of The University Of Illinoi S |
Tolerogenic biodegradable artificial antigen presenting system
|
US20070190032A1
(en)
|
2006-02-13 |
2007-08-16 |
Oncolytics Biotech Inc. |
Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
US8568487B2
(en)
|
2006-02-27 |
2013-10-29 |
Biomet Manufacturing, Llc |
Patient-specific hip joint devices
|
CN101448848B
(zh)
|
2006-03-27 |
2013-12-04 |
全球免疫股份有限公司 |
Ras突变及其相关组合物和方法
|
WO2007127377A2
(en)
|
2006-04-28 |
2007-11-08 |
Resolvyx Pharmaceuticals, Inc. |
Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
|
JP5551432B2
(ja)
|
2006-05-25 |
2014-07-16 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
遺伝子不活性化のための方法と組成物
|
DK3023500T3
(da)
|
2006-06-21 |
2020-04-20 |
Uniqure Ip Bv |
Insektceller til fremstilling af AAV-vektorer
|
EP1880729A1
(en)
|
2006-07-20 |
2008-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of soluble CD160 to suppress immunity
|
EP2051987B1
(en)
|
2006-08-18 |
2014-11-19 |
Argos Therapeutics, Inc. |
Use of cd83 in combination therapies
|
US20120269774A1
(en)
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
WO2008073558A2
(en)
|
2006-10-05 |
2008-06-19 |
The Johns Hopkins University |
Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
|
CN101646418B
(zh)
|
2006-10-12 |
2013-07-17 |
昆士兰大学 |
调节免疫应答的组合物和方法
|
CA2702340C
(en)
|
2006-10-12 |
2014-12-16 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
US20100112077A1
(en)
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
WO2008064357A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Florida Research Foundation, Inc. |
Nanoparticles for protection of cells from oxidative stress
|
WO2008069942A2
(en)
|
2006-12-05 |
2008-06-12 |
Biogen Idec Ma Inc. |
Novel methods of enhancing delivery of a gene therapy vector using steroids
|
EP3070169B1
(en)
|
2006-12-14 |
2018-05-09 |
Dow AgroSciences LLC |
Optimized non-canonical zinc finger proteins
|
JP5694668B2
(ja)
|
2006-12-29 |
2015-04-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
自己免疫疾患の診断上および治療上の標的ならびにその用途
|
JP5357782B2
(ja)
|
2007-02-21 |
2013-12-04 |
バクシネックス インコーポレーティッド |
抗原負荷CD1d分子によるNKT細胞活性の調節
|
KR20080078204A
(ko)
|
2007-02-22 |
2008-08-27 |
크레아젠 주식회사 |
면역억제능이 증가된 간엽줄기세포-매개 자가유래수지상세포
|
CA2680227C
(en)
|
2007-03-07 |
2021-01-26 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
PT2131821T
(pt)
|
2007-03-07 |
2018-10-10 |
Abraxis Bioscience Llc |
Nanopartícula que compreende rapamicina e albumina como agente anticancerígeno
|
US9114071B2
(en)
|
2007-04-04 |
2015-08-25 |
Sigmoid Pharma Limited |
Oral pharmaceutical composition
|
WO2008124639A2
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
US20090226525A1
(en)
|
2007-04-09 |
2009-09-10 |
Chimeros Inc. |
Self-assembling nanoparticle drug delivery system
|
WO2008127532A1
(en)
|
2007-04-12 |
2008-10-23 |
Emory University |
Novel strategies for delivery of active agents using micelles and particles
|
US8877917B2
(en)
|
2007-04-23 |
2014-11-04 |
Alnylam Pharmaceuticals, Inc. |
Glycoconjugates of RNA interference agents
|
US20080311140A1
(en)
|
2007-05-29 |
2008-12-18 |
Baylor College Of Medicine |
Antigen specific immunosuppression by dendritic cell therapy
|
WO2008150868A1
(en)
|
2007-05-29 |
2008-12-11 |
The Board Of Trustees Of The University Of Illinois |
Methods for inducing therapeutic t cells for immune diseases
|
EA200901621A1
(ru)
|
2007-06-05 |
2010-06-30 |
Новартис Аг |
Индукция толерогенного фенотипа у зрелых дендритных клеток
|
US20090004259A1
(en)
|
2007-06-14 |
2009-01-01 |
Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) |
Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cells
|
KR20100042280A
(ko)
|
2007-07-09 |
2010-04-23 |
아스트라제네카 아베 |
Mtor 키나제 및/또는 pi3k와 연관된 질환에 사용되는 모르폴리노 피리미딘 유도체
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
ES2708856T3
(es)
|
2007-08-03 |
2019-04-11 |
Pasteur Institut |
Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales
|
EP2083856B1
(en)
|
2007-08-15 |
2010-09-29 |
Circassia Limited |
Peptides for desensibilization against allergens
|
CA2700378A1
(en)
|
2007-09-21 |
2009-03-29 |
Cytimmune Sciences, Inc. |
Nanotherapeutic colloidal metal compositions and methods
|
US10736848B2
(en)
|
2007-10-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
ES2422291T3
(es)
|
2007-10-31 |
2013-09-10 |
Prec Biosciences Inc |
Meganucleasas monocatenarias diseñadas racionalmente con secuencias de reconocimiento no palindrómicas
|
WO2009062502A1
(en)
|
2007-11-13 |
2009-05-22 |
Dandrit Biotech A/S |
Method for generating tolerogenic dendritic cells employing decreased temperature
|
JP2011505809A
(ja)
|
2007-12-07 |
2011-03-03 |
プレシジョン バイオサイエンシズ,インク. |
ヒトゲノムのDNase高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ
|
CN101970051A
(zh)
*
|
2007-12-31 |
2011-02-09 |
纳诺科尔治疗公司 |
用于治疗心力衰竭的rna干扰
|
WO2009100394A2
(en)
|
2008-02-08 |
2009-08-13 |
Terumo Kabushiki Kaisha |
Device for local intraluminal transport of a biologically and physiologically active agent
|
EP2262489A2
(en)
|
2008-02-28 |
2010-12-22 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
CA2722184A1
(en)
|
2008-04-25 |
2009-10-29 |
Duke University |
Regulatory b cells and their uses
|
JP5727367B2
(ja)
|
2008-05-15 |
2015-06-03 |
ダイナバックス テクノロジーズ コーポレイション |
免疫賦活オリゴヌクレオチドを使用する長期疾患改良
|
JP5549014B2
(ja)
|
2008-05-27 |
2014-07-16 |
国立大学法人名古屋大学 |
免疫調節剤及びその利用
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
ES2462090T5
(es)
|
2008-06-16 |
2017-07-12 |
Pfizer Inc. |
Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
|
US20110070154A1
(en)
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
EP2331124A1
(en)
|
2008-08-15 |
2011-06-15 |
Circassia Limited |
T-cell antigen peptide from allergen for stimulation of il-10 production
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
JP5702723B2
(ja)
|
2008-09-04 |
2015-04-15 |
ザ ジェネラル ホスピタル コーポレイション |
声帯および軟組織の増強および修復用ヒドロゲル
|
US8871515B2
(en)
|
2008-09-17 |
2014-10-28 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
CN101676291B
(zh)
|
2008-09-18 |
2012-05-09 |
上海海和药物研究开发有限公司 |
一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
|
US8889124B2
(en)
|
2008-09-25 |
2014-11-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Tolerogenic populations of dendritic cells
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
JP5552630B2
(ja)
|
2008-10-24 |
2014-07-16 |
学校法人 聖マリアンナ医科大学 |
Htlv−i関連脊髄症を治療または予防するための医薬、およびhtlv−i関連脊髄症の患者に対する抗体療法の効果を試験する方法
|
EP4174178A1
(en)
|
2008-10-24 |
2023-05-03 |
Sarepta Therapeutics, Inc. |
Multiple exon skipping compositions for dmd
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
ES2776126T3
(es)
|
2008-12-15 |
2020-07-29 |
Pfizer |
Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
|
TW201039843A
(en)
|
2009-01-20 |
2010-11-16 |
Myelin Repair Foundation Inc |
Compositions and methods for induced tolerance
|
EP2218784A1
(en)
*
|
2009-02-04 |
2010-08-18 |
Universität Leipzig |
Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
|
CN102307893B
(zh)
|
2009-02-05 |
2014-03-26 |
切尔卡西亚有限公司 |
用于疫苗的草肽
|
KR20100099849A
(ko)
|
2009-03-04 |
2010-09-15 |
동국대학교 산학협력단 |
면역억제제와 트랜스글루타미나제 2의 억제제를 함유한 아토피 피부염 치료용 조성물
|
WO2010114948A2
(en)
|
2009-04-02 |
2010-10-07 |
University Of Florida Research Foundation, Inc. |
An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
MX2011011134A
(es)
|
2009-04-21 |
2012-01-31 |
Selecta Biosciences Inc |
Agentes inmunonanoterapeuticos que proporcionan una respuesta sesgada hacia th1.
|
US20100273220A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
JP5740390B2
(ja)
|
2009-04-27 |
2015-06-24 |
イミューロン リミテッドImmuron Limited |
病的障害の治療および/または予防において使用するための抗lps強化免疫グロブリン製剤
|
KR20180026571A
(ko)
|
2009-05-27 |
2018-03-12 |
셀렉타 바이오사이언시즈, 인크. |
면역조절제를 pH 감응성으로 방출하는 표적화된 합성 나노운반체
|
US9377454B2
(en)
|
2009-06-25 |
2016-06-28 |
Crealta Pharmaceuticals Llc |
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
|
AU2010293059B2
(en)
|
2009-08-26 |
2017-03-16 |
Selecta Biosciences, Inc. |
Compositions that induce T cell help
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
EP2305277A1
(en)
|
2009-09-18 |
2011-04-06 |
Forskarpatent I Syd AB |
Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
|
EP2480659A2
(en)
|
2009-09-24 |
2012-08-01 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
US20120283318A1
(en)
|
2009-10-05 |
2012-11-08 |
Mei Ya-Fang |
Replicating viral vectors for gene therapy
|
CN101703781A
(zh)
|
2009-10-28 |
2010-05-12 |
陕西北美基因股份有限公司 |
一种免疫抑制剂的磁性载药方法
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
EP3431603A1
(en)
|
2009-11-12 |
2019-01-23 |
The University Of Western Australia |
Antisense molecules and methods for treating pathologies
|
CN106834320B
(zh)
|
2009-12-10 |
2021-05-25 |
明尼苏达大学董事会 |
Tal效应子介导的dna修饰
|
KR101267813B1
(ko)
|
2009-12-30 |
2013-06-04 |
주식회사 삼양바이오팜 |
향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
WO2011097511A1
(en)
|
2010-02-05 |
2011-08-11 |
The United States Of America, As Represented By The Secretary Department Of Health & Human Services |
REGULATORY B CELLS (tBREGS) AND THEIR USE
|
EP2660318A1
(en)
|
2010-02-09 |
2013-11-06 |
Sangamo BioSciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
WO2011109833A2
(en)
|
2010-03-05 |
2011-09-09 |
President And Fellows Of Harvard College |
Induced dendritic cell compositions and uses thereof
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
US20110272836A1
(en)
|
2010-04-12 |
2011-11-10 |
Selecta Biosciences, Inc. |
Eccentric vessels
|
WO2011139911A2
(en)
|
2010-04-29 |
2011-11-10 |
Isis Pharmaceuticals, Inc. |
Lipid formulated single stranded rna
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
BR112012028557A2
(pt)
|
2010-05-07 |
2019-09-24 |
Xoma Technology Ltd. |
uso de um anticorpo anti-il-1b ou de fragmentos de ligação do mesmo.
|
MX2012013713A
(es)
|
2010-05-26 |
2013-01-28 |
Selecta Biosciences Inc |
Composiciones de nanovehiculos con adyuvante no acoplado.
|
NZ707377A
(en)
|
2010-06-07 |
2015-09-25 |
Abraxis Bioscience Llc |
Combination therapy methods for treating proliferative diseases
|
US10131875B2
(en)
|
2010-08-04 |
2018-11-20 |
Duke University |
Regulatory B cells and their uses
|
CA2807942C
(en)
|
2010-08-10 |
2021-07-27 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
US20120064110A1
(en)
|
2010-08-20 |
2012-03-15 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
|
CN103079589A
(zh)
|
2010-08-23 |
2013-05-01 |
西莱克塔生物科技公司 |
用于诱导对抗原的免疫应答的靶向多表位剂型
|
CA2810842C
(en)
|
2010-09-09 |
2018-06-26 |
Micell Technologies, Inc. |
Macrolide dosage forms
|
CA2815422A1
(en)
|
2010-10-22 |
2012-04-26 |
University Of Florida Research Foundation, Inc. |
Antigen-specific, tolerance-inducing microparticles and uses thereof
|
US9994443B2
(en)
|
2010-11-05 |
2018-06-12 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
CA2826836A1
(en)
|
2011-02-08 |
2012-08-16 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Antisense oligonucleotides
|
WO2012112578A2
(en)
|
2011-02-14 |
2012-08-23 |
The Children's Hospital Of Philadelphia |
Improved aav8 vector with enhanced functional activity and methods of use thereof
|
US8654487B2
(en)
|
2011-03-11 |
2014-02-18 |
Siemens Industry, Inc. |
Methods, systems, and apparatus and for detecting parallel electrical arc faults
|
EA201391392A1
(ru)
|
2011-03-25 |
2014-04-30 |
Селекта Байосайенсиз, Инк. |
Синтетические наноносители с осмотически опосредованным высвобождением
|
WO2012145509A2
(en)
|
2011-04-19 |
2012-10-26 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors, and viruses
|
EP3699286A1
(en)
|
2011-04-20 |
2020-08-26 |
The Trustees of the University of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
EP3679933A1
(en)
*
|
2011-04-29 |
2020-07-15 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
CN109620830A
(zh)
|
2011-05-16 |
2019-04-16 |
建新公司 |
使用甲氨蝶呤诱导免疫耐受性
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性tリンパ球(ctl)免疫応答を生成する合成ナノキャリア
|
US20130058894A1
(en)
|
2011-09-06 |
2013-03-07 |
Selecta Biosciences, Inc. |
Therapeutic protein-specific induced tolerogenic dendritic cells and methods of use
|
EP2753362A4
(en)
|
2011-09-08 |
2015-04-15 |
Univ Florida |
MATERIALS AND METHODS FOR MODULATING THE IMMUNE RESPONSE
|
US8865487B2
(en)
|
2011-09-20 |
2014-10-21 |
General Electric Company |
Large area hermetic encapsulation of an optoelectronic device using vacuum lamination
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
SG11201400701WA
(en)
|
2011-10-11 |
2014-08-28 |
Aliophtha Ag |
Regulation of receptor expression through delivery of artificial transcription factors
|
WO2013058812A1
(en)
|
2011-10-19 |
2013-04-25 |
President And Fellows Of Harvard College |
Targeted delivery to pancreatic islet endothelial cells
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
IL293434B2
(en)
|
2011-11-18 |
2024-05-01 |
Alnylam Pharmaceuticals Inc |
RNAI factors, preparations and methods of using them for the treatment of transthyretin-related diseases
|
JP6348064B2
(ja)
|
2011-11-22 |
2018-06-27 |
ザ チルドレンズ ホスピタル オブ フィラデルフィア |
効率の高いトランスジーン送達のためのウイルスベクター
|
CN104520428B
(zh)
|
2012-02-17 |
2018-09-21 |
费城儿童医院 |
将基因转移到细胞、器官和组织的aav载体组合物和方法
|
RU2650811C2
(ru)
|
2012-02-24 |
2018-04-17 |
Фред Хатчинсон Кэнсер Рисерч Сентер |
Композиции и способы лечения гемоглобинопатии
|
CN103316356B
(zh)
|
2012-03-22 |
2016-08-17 |
北京三诺佳邑生物技术有限责任公司 |
一种重组慢病毒载体制剂
|
US9506041B2
(en)
|
2012-03-26 |
2016-11-29 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Delivery of packaged RNA to mammalian cells
|
RU2683497C2
(ru)
|
2012-04-18 |
2019-03-28 |
Дзе Чилдрен'З Хоспитал Оф Филадельфия |
Композиция и способы высокоэффективного переноса генов с помощью вариантов капсида aav
|
CN109876139A
(zh)
|
2012-04-24 |
2019-06-14 |
俄亥俄州国家创新基金会 |
用于治疗和预防猪繁殖与呼吸综合征的组合物和方法
|
US9738879B2
(en)
|
2012-04-27 |
2017-08-22 |
Duke University |
Genetic correction of mutated genes
|
WO2014022739A2
(en)
|
2012-08-03 |
2014-02-06 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
US20150231241A1
(en)
|
2012-08-14 |
2015-08-20 |
Ibc Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
ES2878650T3
(es)
|
2012-09-06 |
2021-11-19 |
Univ Chicago |
Polinucleótidos antisentido para inducir la omisión de exón y procedimientos de tratamiento de distrofias
|
US20150224209A1
(en)
|
2012-09-14 |
2015-08-13 |
The Regents Of The University Of California |
Lentiviral vector for stem cell gene therapy of sickle cell disease
|
US9181535B2
(en)
|
2012-09-24 |
2015-11-10 |
The Chinese University Of Hong Kong |
Transcription activator-like effector nucleases (TALENs)
|
CN102871966B
(zh)
|
2012-10-19 |
2013-11-20 |
东南大学 |
用于改善雷帕霉素生物利用度的纳米载药颗粒及其制备方法
|
US9624510B2
(en)
|
2013-03-01 |
2017-04-18 |
The Wistar Institute |
Adenoviral vectors comprising partial deletions of E3
|
RU2015142245A
(ru)
|
2013-03-13 |
2017-04-18 |
Кур Фармасьютикалз Дивелопмент Компани |
Иммуномодифицирующие частицы для лечения воспаления
|
WO2014145524A2
(en)
|
2013-03-15 |
2014-09-18 |
Haplomics, Inc. |
Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a
|
EA201591792A1
(ru)
|
2013-03-15 |
2016-02-29 |
Сарепта Терапьютикс, Инк. |
Улучшенные композиции для лечения мышечной дистрофии
|
US9828587B2
(en)
|
2013-04-08 |
2017-11-28 |
University Of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
KR20220025911A
(ko)
|
2013-05-03 |
2022-03-03 |
셀렉타 바이오사이언시즈, 인크. |
Cd4+ 조절 t 세포를 증진시키기 위한 방법 및 조성물
|
CA2910579C
(en)
|
2013-05-03 |
2023-09-26 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
RU2015154721A
(ru)
|
2013-05-22 |
2017-06-27 |
Элнилэм Фармасьютикалз, Инк. |
КОМПОЗИЦИИ НА ОСНОВЕ RNAi SERPINA1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
US11414695B2
(en)
|
2013-05-29 |
2022-08-16 |
Agilent Technologies, Inc. |
Nucleic acid enrichment using Cas9
|
HUE052233T2
(hu)
|
2013-06-04 |
2021-04-28 |
Selecta Biosciences Inc |
Nem immunszuppresszív, antigénre specifikus immunterápiás ágensek ismételt beadása
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
WO2015051199A2
(en)
|
2013-10-06 |
2015-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified pseudomonas exotoxin a
|
US20150166985A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting von willebrand factor point mutations
|
US9300930B2
(en)
*
|
2014-02-18 |
2016-03-29 |
Microvision, Inc. |
Multi-segment brightness compensation
|
CN105377481B
(zh)
*
|
2014-02-27 |
2018-02-06 |
宁夏东方钽业股份有限公司 |
一种高纯钽粉及其制备方法
|
US10339920B2
(en)
*
|
2014-03-04 |
2019-07-02 |
Amazon Technologies, Inc. |
Predicting pronunciation in speech recognition
|
EP2916319A1
(en)
*
|
2014-03-07 |
2015-09-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Concept for encoding of information
|
WO2015138357A2
(en)
|
2014-03-09 |
2015-09-17 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of otc deficency
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
US20160220501A1
(en)
|
2015-02-03 |
2016-08-04 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
US20150359865A1
(en)
|
2014-06-17 |
2015-12-17 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
|
WO2015200728A1
(en)
|
2014-06-25 |
2015-12-30 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
KR20170045344A
(ko)
|
2014-09-07 |
2017-04-26 |
셀렉타 바이오사이언시즈, 인크. |
항-바이러스 전달 벡터 면역 반응을 약화시키기 위한 방법 및 조성물
|
EA201790977A1
(ru)
|
2014-11-05 |
2017-10-31 |
Селекта Байосайенсиз, Инк. |
Способы и композиции, относящиеся к применению поверхностно-активных веществ с низким показателем гидрофильно-липофильного баланса (hlb) при получении синтетических наноносителей, включающих рапалог
|
WO2017139212A1
(en)
|
2016-02-08 |
2017-08-17 |
Cyta Therapeutics, Inc. |
Particle delivery of rapamycin to the liver
|
CA3013896A1
(en)
|
2016-02-10 |
2017-08-17 |
Pfizer Inc. |
Therapeutic nanoparticles having egfr ligands and methods of making and using same
|
EP3426285B1
(en)
|
2016-03-11 |
2024-05-29 |
Cartesian Therapeutics, Inc. |
Formulations and doses of pegylated uricase
|
US10545815B2
(en)
*
|
2016-08-03 |
2020-01-28 |
Futurewei Technologies, Inc. |
System and method for data redistribution in a database
|
WO2018039465A1
(en)
|
2016-08-25 |
2018-03-01 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
EP3518956A1
(en)
|
2016-09-27 |
2019-08-07 |
Selecta Biosciences, Inc. |
Recombinant immunotoxins for use in the treatment of cancer
|
US11104887B2
(en)
|
2017-01-03 |
2021-08-31 |
Ethris Gmbh |
Ornithine transcarbamylase coding polyribonucleotides and formulations thereof
|
KR20190104194A
(ko)
|
2017-01-07 |
2019-09-06 |
셀렉타 바이오사이언시즈, 인크. |
합성 나노담체에 커플링된 면역억제제의 패턴화된 투여
|
MX2019010757A
(es)
|
2017-03-11 |
2020-01-20 |
Selecta Biosciences Inc |
Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor.
|
KR20200086670A
(ko)
|
2017-10-13 |
2020-07-17 |
셀렉타 바이오사이언시즈, 인크. |
항바이러스 전달 벡터 IgM 반응을 약화시키기 위한 방법 및 조성물
|
JP7416430B2
(ja)
|
2018-02-26 |
2024-01-17 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム リミテッド |
薬物送達システム
|
WO2019217552A1
(en)
|
2018-05-09 |
2019-11-14 |
Yale University |
Particles for spatiotemporal release of agents
|
JP2021530571A
(ja)
|
2018-07-16 |
2021-11-11 |
セレクタ バイオサイエンシーズ インコーポレーテッドSelecta Biosciences, Inc. |
Mmaコンストラクトおよびベクターの方法および組成物
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
MX2021013163A
(es)
|
2019-04-28 |
2022-02-21 |
Selecta Biosciences Inc |
Métodos para el tratamiento de sujetos con inmunidad preexistente a vectores de transferencia viral.
|
MX2021014566A
(es)
|
2019-05-28 |
2022-03-22 |
Selecta Biosciences Inc |
Métodos y composiciones para la respuesta inmune atenuada anti-vector de transferencia viral.
|
CN114207440A
(zh)
|
2019-06-04 |
2022-03-18 |
西莱克塔生物科技公司 |
聚乙二醇化尿酸酶的制剂和剂量
|
JP2022553345A
(ja)
|
2019-10-21 |
2022-12-22 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
肝疾患および肝障害を処置するための方法および組成物
|
MX2022005506A
(es)
|
2019-11-08 |
2022-08-10 |
Selecta Biosciences Inc |
Formulaciones y dosis de uricasa pegilada.
|
CA3174988A1
(en)
|
2020-03-11 |
2021-09-16 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|